A Smart + Strong Site
Subscribe to:
• E-newsletters
• POZ magazine
POZ Personals
Sign In / Join		 Username:
 Password:
Back to home » Top Stories » IAC 2008
IAC 2008 XVII International AIDS Conference
Mexico City, Mexico
August 3-8, 2008

Future Options for the Treatment Experienced

August 12, 2008

At the XVII International AIDS Conference in Mexico City, David Evans talks with Andrew Carr, MD, Professor of Medicine at the University of New South Wales in Sydney, Australia, who shares his views on the future of HIV treatment and what's in the pipeline for people with HIV who've been on many treatment regimens.

 

9 1/4 minutes. Click here to view the transcript.

Scroll down to comment on this story.

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 1 (of 1 total)    

mark, , 2008-08-13 12:48:10
the transcript is so much more important...

comments 1 - 1 (of 1 total)    

Our general International AIDS Conference coverage is made possible with a charitable grant from Bristol-Myers Squibb.
More from IAC 2008

Starting and Switching Treatment

August 12, 2008
Isentress, Intelence and Prezista Combo Shines for Treatment Veterans
Studies Disagree on Abacavir for Patients With High Viral Loads
August 6, 2008
Isentress Continues to Show Well Versus Sustiva as First-Line Treatment
Stigma, Fear of Side Effects, Keep Many off Treatment
Sustiva Bests Kaletra for Treatment of Advanced HIV Disease
August 5, 2008
Some Gender and Racial Differences with Three Protease Inhibitors
August 4, 2008
Similar Survival Among IDUs on ARV Treatment

HIV/AIDS Complications

August 15, 2008
Milk Thistle Shows Potential for Hep C
August 14, 2008
Defining the Risk Factors for Kidney Damage in Patients Using Tenofovir
August 13, 2008
Encouraging Data From Second Tesamorelin Study for Lipo
August 11, 2008
Abacavir and Cardiovascular Risk: Is There or Isn’t There?
August 7, 2008
Abacavir and Heart Attack Risk: Round 2
August 6, 2008
Hep C: The Other Epidemic

Experimental HIV Drugs

August 15, 2008
Norvir Tablets Similar to Capsules, Expected in 2009
August 12, 2008
Future Options for the Treatment Experienced
New Options for Those New to Treatment
August 11, 2008
IDX899 Safe, Reduces Viral Load in Preliminary Study
August 8, 2008
New NNRTI RDEA806 Shows Promise in Seven-Day Study
August 6, 2008
NNRTI Rilpivirine (TMC-278) Comparable to Sustiva in 96-Week Study

HIV Transmission and Prevention

August 18, 2008
Vaccines: Lessons Learned
August 15, 2008
PrEP: Preparing For Success?
August 14, 2008
New HIV Numbers: New Prevention Strategy? Part 1
New HIV Numbers: New Prevention Strategy? Part 2
August 7, 2008
Microbicides: Assessing Progress
Having Children a Priority for Many Positive Women
August 5, 2008
Report: Now Is Time to Prepare for PrEP
August 3, 2008
Annual HIV Infections in U.S. Substantially Higher Than Believed

Global HIV/AIDS

August 19, 2008
AIDS Activism For The Next Decade
August 15, 2008
Human Rights Struggles Define AIDS Fight
August 8, 2008
Achieving Universal Treatment Access: The Experience in Rural Malawi
August 6, 2008
Stigma, Fear of Side Effects, Keep Many off Treatment
August 4, 2008
Shortage of Health Care Workers Threatens African HIV Care
IAC Panelists: Scale Up, Leadership and Youth Crucial to HIV Response

Regan's Blog

August 6, 2008
La Voz Global
August 4, 2008
Bienvenidos a AIDS 2008!


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.